PATENT CLAIM ANALYSIS

Application Number: 16058886
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-05
Patent Classification: ["424", "233100"]

Abstract:
Modified E1a regulatory sequences are provided, wherein at least one Pea3 binding site, or a functional portion thereof, is deleted. Also provided are modified E1a sequences that selectively express particular isoforms. Also provided is an E1b-19K clone insertion site. These modified sequences can be used individually, or in combination with one another, to provide tumor-selective expression of proteins.

Claim (Index 32):
The recombinant adenovirus of  claim 31 , wherein said insertion site comprises a deletion of 202 base pairs following said start site of E1b-19K.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 96.0
- Lexical Diversity: 1.39583
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13254825', '15834690', '10669768', '09351778', '14648661']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7561779476904947
- 35 USC 102 Novelty (BERT): 0.7330315653932039
- Combined Prediction Score: 0.7538633094607656
- Mean Citation Score: 537.3009
- Max Citation Score: 931.03784
- Similarity Product: 780.6505552397872

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test